Levofloksacin Unimed Pharma (Levofloxacin Hemihydrate)

Levofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. This inhibition stops bacterial cell division, leading to bacterial death and resolution of the infection.

The specific dosing regimen for Levofloksacin Unimed Pharma is determined by the prescribing clinician based on the type and severity of the ocular infection, patient age, and other clinical factors.

Safety data for levofloxacin in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levofloksacin belongs to the fluoroquinolone class, offering broad‑spectrum activity against many gram‑negative and gram‑positive ocular pathogens. Compared with older agents like chloramphenicol, it often provides faster bacterial eradication and a lower risk of resistance, though individual choice depends on susceptibility patterns and patient factors.

Store the ophthalmic solution at room temperature, below 25 °C, in its original container. Protect it from light and moisture, and keep the cap tightly closed when not in use to maintain sterility.

Levofloksacin Unimed Pharma is applied topically to the affected eye(s) as directed by the prescriber, typically using a dropper to instill the recommended number of drops at specified intervals.

Serious risks include severe allergic reactions, Stevens‑Johnson syndrome, tendon rupture, and worsening of corneal ulcers. Patients should seek immediate medical attention if they experience intense eye pain, vision changes, rash, or systemic symptoms.

Individuals with a known hypersensitivity to levofloxacin, other fluoroquinolones, or any component of the formulation should avoid this product. Caution is also advised for patients with a history of tendon disorders, uncontrolled diabetes, or those taking systemic fluoroquinolones.